Ribosomal protein S12 and aminoglycoside antibiotics modulate A-site mRNA cleavage and transfer-messenger RNA activity in Escherichia coli

J Biol Chem. 2009 Nov 13;284(46):32188-200. doi: 10.1074/jbc.M109.062745. Epub 2009 Sep 23.

Abstract

Translational pausing in Escherichia coli can lead to mRNA cleavage within the ribosomal A-site. A-site mRNA cleavage is thought to facilitate transfer-messenger RNA (tmRNA).SmpB- mediated recycling of stalled ribosome complexes. Here, we demonstrate that the aminoglycosides paromomycin and streptomycin inhibit A-site cleavage of stop codons during inefficient translation termination. Aminoglycosides also induced stop codon read-through, suggesting that these antibiotics alleviate ribosome pausing during termination. Streptomycin did not inhibit A-site cleavage in rpsL mutants, which express streptomycin-resistant variants of ribosomal protein S12. However, rpsL strains exhibited reduced A-site mRNA cleavage compared with rpsL(+) cells. Additionally, tmRNA.SmpB-mediated SsrA peptide tagging was significantly reduced in several rpsL strains but could be fully restored in a subset of mutants when treated with streptomycin. The streptomycin-dependent rpsL(P90K) mutant also showed significantly lower levels of A-site cleavage and tmRNA.SmpB activity. Mutations in rpsD (encoding ribosomal protein S4), which suppressed streptomycin dependence, were able to partially restore A-site cleavage to rpsL(P90K) cells but failed to increase tmRNA.SmpB activity. Taken together, these results show that perturbations to A-site structure and function modulate A-site mRNA cleavage and tmRNA.SmpB activity. We propose that tmRNA.SmpB binds to streptomycin-resistant rpsL ribosomes less efficiently, leading to a partial loss of ribosome rescue function in these mutants.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Blotting, Northern
  • Blotting, Western
  • DNA Primers / chemistry
  • Drug Resistance, Bacterial
  • Escherichia coli / drug effects*
  • Escherichia coli / metabolism*
  • Escherichia coli Proteins
  • Luciferases / metabolism
  • Mutation / genetics
  • Paromomycin / pharmacology
  • Protein Biosynthesis / drug effects
  • Protein Conformation
  • Protein Synthesis Inhibitors / pharmacology
  • RNA, Bacterial / metabolism*
  • RNA, Messenger / metabolism*
  • RNA-Binding Proteins / metabolism*
  • Ribosomal Protein S9
  • Ribosomal Proteins / genetics
  • Ribosomal Proteins / metabolism*
  • Ribosomes / metabolism*
  • Streptomycin / pharmacology

Substances

  • Anti-Bacterial Agents
  • DNA Primers
  • Escherichia coli Proteins
  • Protein Synthesis Inhibitors
  • RNA, Bacterial
  • RNA, Messenger
  • RNA-Binding Proteins
  • Ribosomal Protein S9
  • Ribosomal Proteins
  • RpsI protein, E coli
  • ribosomal protein S12
  • ribosomal protein S4
  • small protein B
  • tmRNA
  • Paromomycin
  • Luciferases
  • Streptomycin